Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Multicenter Randomized Double-blind Placebo-controlled Study in Parallel Groups to Evaluate the Efficacy, Safety, and Tolerability of the Drug 4-MUST, Tablets, 128 mg Administered at Various Doses in Patients With Chronic Cholecystitis and Biliary Dyskinesia

NCT06842966 is registered in ClinicalTrials.gov with Valenta Pharm JSC as lead sponsor.

NCT NCT06842966
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06842966 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Multicenter Randomized Double-blind Placebo-controlled Study in Parallel Groups to Evaluate the Efficacy, Safety, and Tolerability of the Drug 4-MUST, Tablets, 128 mg Administered at Various Doses in Patients With Chronic Cholecystitis and Biliary Dyskinesia
Lead sponsor
Valenta Pharm JSC
Phase
Phase 2
Overall status
Recruiting
Start date
October 17, 2024
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

biliary dyskinesia, chronic cholecystitis